Rifabutin: Is it useful in the treatment of multidrug-resistant tuberculosis?

• S. Tiberi,
• L. D’Ambrosio,
• R. Centis,
• G.B. Migliori

Affiliations

S. Tiberi

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, UK; Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK

L. D’Ambrosio

World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy; Public Health Consulting Group, Lugano, Switzerland

R. Centis

World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy

G.B. Migliori

Corresponding author at: WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, via Roncaccio 16, 21049, Tradate (VA), Italy.; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy